SynthesisMedicine2016

Efficacy and safety of addition of bevacizumab to FOLFIRI or irinotecan/bolus 5-FU/LV (IFL) in patients with metastatic colorectal cancer: A meta-analysis.

Ke Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.